baber/WOPTO huggingface dataset:
Patent NZ-311000-A (NZ)
Title: Vaccine comprising a polysaccharide antigen-carrier protein conjugate and a free carrier protein
Inventor: SLAOUI MONCEF MOHAMED
IPC: A61K39/116
Filed: 1996-06-04
Abstract: The present invention relates to combination vaccines comprising a conjugated polysaccharide antigen linked to a carrier protein, and wherein the carrier protein is also present as a free antigen in the vaccine composition, characterised in that the ratio of polysaccharide to protein is from 1:0:3 to 1:2. In particular the vaccine composition of the present invention relates to a multivalent vaccine, that is a vaccine for the amelioration or treatment of more than one disease states. The present invention also relates to the production and use of such a vaccine in medicine.
Patent NZ-331125-A (NZ)
Title: Improved coffee creamer and other cups and tubs
Inventor: REDMOND SANFORD
IPC: B65D77/20
Filed: 1997-01-31
Abstract: his container is thermoformed from a relatively thin flat plastic film comprising an upright standing hollow containment formation (100) having an upper flat rim (102) to which a thin cover member (103) is sealingly attached in a sealing pattern . The sealing rim encompassing the containment formation with at least a portion of the sealing rim extending outwardly from the hollow containment formation an amount adequate to permit it to function as a tab (104).  The extending tab portion (104) has a fault line (101) on its underside traversing the tab at a right angle to a centerline extending outwardly from the hollow containment formation which when the tab portion (104) is upwardly bent causes the tab to rupture at the fault line (101).  The rupturing causes the outer tab portion to break away from the remaining tab portion while remaining sealed to the thin cover member which is also upwardly bent to create an outlet passage for flowable material between the remaining tab portion and the thin cover.
Patent NZ-337390-A (NZ)
Title: a blooming type concentrated disinfectant composition containing a volatile hydrophobic solvent, a hydrophilic solvent, a nonionic surfactant, a hydrotrope and a nonphenolic compound
Inventor: CRISANTI MICHAEL GEORGE
IPC: A01N25/04
Filed: 1998-02-06
Abstract: An aqueous liquid disinfectant concentrate composition, which is a blooming type, comprises: a) a volatile hydrophobic solvent; b) a hydrophilic solvent which stabilizes the volatile hydrophobic solvent; c) a nonionic surfactant which is either i) a nonionic alkoxylated fatty alcohol surfactant having a HLB value of 10 to 15 or ii) a block copolymer; d) a combination of iii) a fatty alcohol ethoxylate or propoxylate having 2-3 ethoxylation and/or propoxylation and a HLB value of 7 and 9 with iv) an alkanolamide wherein the ratio of iii) to iv) is 10.0 to -1.0:1; e) a nonphenolic compound which is effective in providing a germicidal effect; f) hydrotrope; g) water and h) one or more optional constituent such as preservatives, fragrances, colouring agents, thickeners, pH adjusting agents, chelating agents, buffers and cloud point modifiers. Blooming is characterized as the formation of milky, creamy or cloudy appearance, which is manifested when a concentrated composition is added to a larger volume of water. The block polymer has the formula (PO)l(EO)m(PO)n or (EO)l(PO)m(EO)n wherein: l, m and n are integer values selected so that the resulting block copolymer surfactant exhibits an HLB value of at least about 10; EO represents an ethoxy group and PO represents a propoxy group.
Patent NZ-502239-A (NZ)
Title: Synergistic antimicrobial compositions containing a dimethylamide of a carboxylic acid with a mixture of 2-(thiocyanomethylthio) benzothiazole and methylene-bis(thiocyanate)
Inventor: KING VANJA M
IPC: A01C1/06
Filed: 1998-07-07
Abstract: Synergistically effective compositions comprising a dimethylamide of a carboxylic acid, with a mixture of 2-(thiocyanomethylthio)benzothiazole and methylene-bis(thiocyanate) for use in controlling the growth of microorganisms in or on a product, material, or medium; allowing safe and economical use over prolonged periods.
Patent NZ-504653-A (NZ)
Title: Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
Inventor: BIANCHINI ROBERT J
IPC: A61K8/37
Filed: 1998-11-19
Abstract: A cosmetic composition with reduced tack, comprising an active ingredient such as an emollient or a fragrance, and a carrier of from 5-50% of a silicone fluid phase with at least one hydroxy functionalised silicone fluid and at least one stabilizing agent, from 40-95% of a gellant/solvent phase of a mixture of dibenzylidene sorbitol and at least one solvent.
Patent NZ-504662-A (NZ)
Title: Spheroids having a core coated with a coating having an thermoplastic excipient
Inventor: DEBREGEAS PATRICE
IPC: A61K31/34
Filed: 1998-11-19
Abstract: Spheroids contain one or more active principles excluding tiagabine comprises a core and a layer coating the core and a flexible and deformable film based on a polymer material wherein the spheroids can be compressed directly by adding less than 5% by weight of an auxiliary substance. The core and the coating layer contain at least one thermoplastic excipient, which is of pasty to semisolid consistency at a temperature of 200C and has a melting point of 25-1000C. The glass transition temperature of the film is less than 300C which ensures either protection or masking of the taste or modified and controlled release of the active principles.
Patent NZ-514572-A (NZ)
Title: Steroidal compounds
Inventor: SOLDATO PIERO DEL
IPC: C07J41/00
Filed: 2000-04-11
Abstract: Steroidal compounds of the formula A-(B)b0-C-N(O)2, wherein: b0 is 0 or 1, A is a steroidal drug radical as defined herein, B is -TB-X2-TBI-, wherein TB and TBI are independently (CO), O, S or NH, and X2 is a bivalent bridging group deriving from the corresponding precursor of B, having the formula Z-TB-X2- TBI-Z', in which Z and Z' are independently H or OH, and the precursor of B is as defined herein. The compounds are used in pharmaceutical preparations, for use in the conditions of oxidative stress and/or endothelial dysfunctions.
Patent NZ-515142-A (NZ)
Title: Pharmaceutical composition
Inventor: DIDRIKSEN ERIK
IPC: A61K31/56
Filed: 2000-01-27
Abstract: A pharmaceutical composition for dermal use, said composition comprising a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue and a second pharmacologically active component B consisting of at least one corticosteroid, characterised in that the difference between the optimum stability pH of said first component A and the optimum pH of said second component B is at least 1; and at least one solvent component C selected from the group consisting of: (i) compounds of the general formula R3 (OCH2C (R') H) xOR2 (I) wherein x is in the range of 2-60, R'in each of the x units independently is H or CH3, R2 is straight chain or branched C120alkyl or benzol, and R3 is H or phenylcarbonyloxy; (ii) di- (straight or branched)-C410 alkyl esters of C4-C8 dicarboxylic acids; (iii) straight or branched C12-1s-alkyl benzoates; (iv) straight or branched C2-4-alkyl esters of straight or branched C1018-alkanoic or alkenoic acids; (v) propylenglycol diesters with C814-alkanoic acids; and (vi) branched primary C1824 alkanols. Also disclosed is the use of said composition to treat psoriasis and related skin disorders.
Patent NZ-515647-A (NZ)
Title: Generation of therapeutic microfoam
Inventor: OSMAN TARIQ
IPC: A61P9/14
Filed: 2000-05-26
Abstract: Improved therapeutic sclerosing microfoams and methods and devices for making them are provided that have advantage in producing a consistent profile injectable foam with minimal input by the physician yet using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen.
Patent NZ-516551-A (NZ)
Title: Biaxially orientated plastic film comprising a thermoplastic polymer and natural fibers, polymer fibres or mineral fibers
Inventor: HUTT DETLEF
IPC: C08L23/10
Filed: 2000-07-12
Abstract: A biaxially oriented polymer film has at least one layer characterized in that this layer is a fibre-containing layer which is built up from a thermoplastic polymer selected form polyimide, polyamide, polyester, PVC or polyolefin and contains natural fibres, polymer fibres or mineral fibres. The polymer film can be used as packaging film, label film, lamination film, or as metallizable film. Also described is a process for the production of a polymer film.
Patent NZ-517250-A (NZ)
Title: Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs (NSAID) and naturally occurring conotoxins
Inventor: MEYTHALER JAY M
IPC: A61K31/609
Filed: 2000-08-10
Abstract: A method for treating a patient/subject having neuronal injury, pain, neurotrauma and/or traumatic brain injury, such as diffuse axonal injury, which includes intrathecally and/or intraventricularly administering to the subject a therapeutically effective amount of a non-steroidal anti-inflammatory drug and/or a naturally occurring omega conotoxin, functional fragment thereof, a pharmacologically acceptable salt, ester, amide, or prodrug thereof.
Patent NZ-517996-A (NZ)
Title: Method for production of proteinaceous substances
Inventor: RESKI RALF
IPC: A01H5/00
Filed: 2000-09-27
Abstract: A method for the production of heterologous proteinaceous substances in plant material, wherein protonema moss tissue is used as plant material and that the proteinaceous substances produced are obtained from the culture medium without disrupting the producing tissues or cells.
Patent NZ-521051-A (NZ)
Title: Drug delivery apparatus
Inventor: CROCKFORD DAVID ROE
IPC: A61M11/06
Filed: 2001-02-12
Abstract: A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug; a sensor (4) for monitoring the breathing pattern of a patient; a controller (24) arranged to control the drug delivery device to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor (4) to begin inhalation, the pulses having a duration which is adjusted by the controller (24) on the basis of the monitored breathing pattern of the patient; a feedback indicator (16) which indicates to a patient whether the monitored breathing pattern is effective for inhaling drug-laden air or not; a dose calculator (25) which calculates the dose delivered to the patient; and an indicator (17) which indicates to the patient when a desired dose has been delivered, whereby the apparatus is configured to deliver the full amount of the desired dose in at least 80 % of treatments.
Patent NZ-522406-A (NZ)
Title: Single copy genomic hybridization probes and method of generating same
Inventor: CAZARRO PATRICIA M
IPC: C12Q1/68
Filed: 2001-05-15
Abstract: A nucleic acid hybridization probe comprises a labelled nucleic acid which will hybridize to a complementary, non-repetitive single copy sequence interval in target nucleic acid of a known sequence. The probe has a length of at least about 50 nucleotides and is free of the sequence of SEQ ID NOs: 1-428 and 447-479. Also described are methods of developing a hybridization probe for a target nucleic acid forming part of a genome and methods for identifying a single copy sequence interval from a target nucleic acid sequence.
Patent NZ-527174-A (NZ)
Title: Pump dispenser having an improved discharge valve
Inventor: NAZARI JOSEPH
IPC: G01F11/00
Filed: 2003-07-24
Abstract: A manual pump dispenser, comprising, a pump body having a pump piston reciprocable between pressure and return strokes in a pump cylinder against the bias of a piston return spring to define with said cylinder a variable volume pump chamber, said pump body having an inlet valve for the inletting of a liquid product to said chamber upon the piston return strokes, a discharge valve snap-fitted to the pump body for the outletting of the liquid product from the chamber upon the piston pressure strokes through a discharge passage of a plunger head mounted to the piston, the discharge valve being formed of an elastomer material and comprising a conically-shaped valve element at one end sloping outwardly toward the discharge passage, the discharge valve having a non-reentrant element at an opposite end thereof, a transverse perforate support web within the pump body, the support web having an opening through which the non-reentrant element extends for snap- fit engagement, the pump body having an annular valve with which an outer surface of the valve element engages in a discharge valve closing position, a portion of the valve element disengaging the valve seat to open flow of the liquid product from the chamber through a discharge port in the support wall and through the discharge passage in a discharge valve open position.
Patent NZ-528140-A (NZ)
Title: Metalloproteinase inhibitors
Inventor: ERIKSSON ANDERS
IPC: C07D405/12
Filed: 2002-03-13
Abstract: A compound of the formula (I) that is suitable for use as metalloproteinase inhibitors, especially as inhibitors of MMP12 is disclosed, wherein Z is SO2(N6) or N(R7)SO2 or N(R7)SO2N(R6), the other variables shown therein are as defined in the specification.
Patent NZ-528725-A (NZ)
Title: Moraxella catarrhalis proteins
Inventor: KYD JENNELLE
IPC: C07K16/12
Filed: 1999-05-11
Abstract: A Branhamella catarrhalis antigen has an apparent molecule mass of about 35 kDa as determined by SDS-PAGE and has the N-terminal sequence TPTVYGKAL. Nucleic acid, host cells, vectors and antibodies are also described. The protein or antigenic fragment can be used for preparing immunogenic composition such as vaccines for the prevention or treatment of respiratory infection or otitis media. Methods of detecting or diagnosing B,catarrhalis comprise detecting the presence of the protein or antibodies in a sample.
Patent NZ-528756-A (NZ)
Title: Oestrus detection system
Inventor: SHARPE JOHNATHAN CHARLES
IPC: A61D17/00
Filed: 2003-12-22
Abstract: An apparatus for determining oestrus in an animal (5) is disclosed. The apparatus includes: a sensor means (2) which is attachable to an animal (5) and capable of detecting a manifestation indicative of oestrus in the animal (5), an indicator means (3) capable of displaying a first state prior to detection of oestrus by said sensing means (2) and displaying a second state which has an altered appearance to the first state after detection of oestrus by the sensor means (2); and an automated visual detection system (4) capable of visually detecting the altered appearance remotely from the animal (5).
Patent NZ-533123-A (NZ)
Title: Solar collector panel for heating ventilation air
Inventor: CHRISTENSEN HANS JORGEN
IPC: F24S10/80
Filed: 2002-11-26
Abstract: A solar collector panel is disclosed for heating of air, in which the conventional insulation material on the back panel facing away from the sun is replaced by a spacing between a permeable back panel and a permeable heat absorber means, so that a heat convection airflow through the back panel and into the interior of the solar energy panel against the temperature gradient prevents the convection heat loss in the opposite direction. The back panel also reduces the radiation heat loss from the heat absorber means. Furthermore, in case the flow of air through the solar energy panel is stopped, the convection-insulation will no longer be effective, and a photovoltaic cell panel placed within the solar energy panel and generating electricity from the solar radiation will not be subjected to the damaging high stagnation temperature of a traditionally insulated solar collector panel.
Patent NZ-533791-A (NZ)
Title: Hemostatic cleaning swab for treating wounds
Inventor: BEAUDRY SCOTT ALEXANDER
IPC: A61F13/38
Filed: 2004-06-25
Abstract: A hemostatic wound cleansing swab comprises a stick and a wound treating element. The stick comprises a proximal portion, a proximal end, a distal portion, a distal end and a reservoir for containing a liquid. The wound treating element is secured to the distal portion and comprises a cleansing element and a hemostatic element for effecting hemostasis of a wound. The reservoir is in fluid communication with the cleansing element and the hemostatic element is discrete from the cleansing element. A swab for treating a wound may also comprise an element for applying liquid to a wound being secured to one end of stick and a hemostatic element being secured to the other end of the stick, and a reservoir being in fluid communication with the element for applying liquid to the wound.
Patent NZ-536049-A (NZ)
Title: Modulation of stem and progenitor cell differentiation, assays, and uses thereof
Inventor: HARIRI ROBERT J
IPC: A61K35/12
Filed: 2003-04-13
Abstract: A method for modulating the differentiation of mammalian stem cells or progenitor cells comprising contacting said stem cells or progenitor cells for at least six days with a compound that inhibits TNF-a activity, under conditions in which said stem cells or progenitor cells differentiate, wherein said compound is an amino-substituted thalidomide analogue or an amino-substituted isoindoline; and with the proviso that said stem cells are not totipotent human stem cells.
Patent NZ-536205-A (NZ)
Title: Keratinocytes expressing exogenous angiogenic growth factors
Inventor: COMER ALLEN
IPC: A61K35/12
Filed: 2003-04-29
Abstract: Provided is a composition comprising normal immortalized keratinocytes (NIKS) cells, said NIKS cells comprising at least one polynucleotide encoding an exogenous angiogenic factor, wherein said polynucleotide is operably linked to a promoter, wherein said NIKS cells are stratified into squamous epithelia, thereby forming cultured skin tissue. The angiogenic factor may be VEGF, angiopoietin-1 or HIF-1, among others. Also provided are similar tissues as skin grafts for use in treating burns and wounds.
Patent NZ-536927-A (NZ)
Title: Wrinkle reduction assembly using two pairs of tensioning rollers, one pair having a chevron pattern
Inventor: SWAFFORD STEVE
IPC: B65H27/00
Filed: 2003-05-08
Abstract: An apparatus and method for reducing wrinkles in a film (102) is disclosed. The apparatus includes a first pair (100) of cylindrical rollers including a first roller (108a) and a second roller (108b), the first and second roller disposed parallel to each other, and each having a substantially smooth surface. Also included are a second pair (110) of cylindrical rollers including a third roller (112a) and a fourth roller (112b), the third and fourth roller disposed parallel to each other, and at least one of the third (112a) and fourth roller (112b) having a chevron pattern disposed on the surface. The first pair of rollers (100) being adjacent to and spaced apart from the second pair of rollers (110). The rollers may be in an open or closed position and all rollers freely rotate.
Patent NZ-537037-A (NZ)
Title: Use of benzophenones for controlling Pseudocercosporella herpotrichoides in crop plants
Inventor: GEWEHR MARKUS
IPC: A01N25/04
Filed: 2003-07-07
Abstract: Disclosed is a use of benzophenones of general formula (I) for controlling Pseudocercosporella herpotrichoides in cultivated plants, wherein the variable R shown in formula (I) represents hydrogen or C1-C4 alkyl and Hal represents fluoride, chlorine, or bromine.
Patent NZ-538241-A (NZ)
Title: Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance
Inventor: WINDISCH MANFRED
IPC: C07D405/12
Filed: 2004-07-01
Abstract: Disclosed are chemical compounds in the form of their racemates, enantiomers or diastereomers with general formula I in which R, where R is not acetylsalicylic acid, stands for the unchanged portion of a NSAID, B stands for a grouping X-R2-Y, and Toc stands for the residue of tocopherol with the formula II and the rest of the substituents are defined in the complete specification. Also disclosed is the use of the above chemical compound in isolated form or in the form of the corresponding physiologically harmless salts and/or solvates for the production of pharmaceutical agents for the treatment or prophylaxis of degenerative diseases of the central nervous system.
Patent NZ-542766-A (NZ)
Title: Contactless type communication tag, portable tag reader for verifying a genuine article, and method for providing information of whether an article is genuine or not
Inventor: PARK MI-KYOUNG
IPC: G07F7/08
Filed: 2004-03-30
Abstract: A contactless communication tag, a portable tag reader, and a method of providing genuineness of a product. The tag reader specifies an encryption key corresponding to an encryption key stored in the tag from its own plurality of encryption keys based on a signal received from the tag. The tag reader receives an encrypted product code or product information from the tag and decrypts the received product code or product code using an encryption key. Also, the tag reader outputs a result of decryption on a 7-segment display window, a plurality of colour light emitting diodes (LED), and/or a liquid crystal display (LCD) window or as beep sounds or voices.
Patent NZ-545774-A (NZ)
Title: Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
Inventor: SHIN HYUN-IK
IPC: C07D471/04
Filed: 2004-10-22
Abstract: The present disclosure provides a process for the preparation of highly pure 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (5) in one-pot four steps using a single solvent, wherein ethyl 3-(2,6-dichloro-5-fluoropyridin-3-yl)-3-oxo-propanoate is used as a starting material, which is reacted with dimethyltrmamide dialkylacetal followed by the steps defined in the specification.
Patent NZ-550781-A (NZ)
Title: Purification of N-(phosphonomethyl)glycine
Inventor: TAI JIMMY JUI
IPC: C07F9/38
Filed: 2005-05-20
Abstract: Provided is a process for the purification of glyphosate (PMG) comprising: 1) dissolving or suspending a material comprising PMG in water, in the presence of a base, to produce a composition comprising a PMG salt in an aqueous base, 2) contacting the composition with an acid, such that the PMG salt is neutralized, forming a precipitate of PMG, and 3) isolating the precipitate of PMG, with the proviso that the composition of step 1) is not concentrated or filtered using a nanofiltration membrane. Further provided are specific bases and reaction conditions for the process
Patent NZ-552328-A (NZ)
Title: Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
Inventor: GILLIGAN MYRA
IPC: C07D261/08
Filed: 2005-08-26
Abstract: Disclosed is a compound of formula (I), with substituents as described in the specification, and its use in medicaments for treating conditions mediated by 5-HT2A receptor activity. Also disclosed is a method of making the compound.
Patent NZ-553734-A (NZ)
Title: Novel thiazole derivatives as NF-kappaB inhibitors
Inventor: LEBAN JOHANN
IPC: C07D401/14
Filed: 2005-07-29
Abstract: Disclosed are thiazole derivatives, containing piperidine or piperazine rings, where the variable substituents are as defined in the specification. Also disclosed is the use of the compounds as NF-kappaB inhibitors, and for treating diseases characterized by a hyperproliferation of T cells.